Medicare is expanding coverage of weight-loss drugs, including GLP-1s, although the specifics of the expansion and its implementation are not entirely clear. The expansion is expected to begin in 2026, with some reports indicating a start date of July 1, and is intended to increase access to these medications for older adults. However, it appears that not all employers are planning to follow suit and expand their own coverage of these drugs.